Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Decursinol Angelate, a chemical compound predominantly found in the roots of medicinal plants such as Angelica Gigas, is celebrated for its diverse therapeutic properties. These include anti-inflammatory, anti-angiogenic, and anti-cancer effects, making it a promising candidate for pharmaceutical applications. Its ability to induce cell cycle arrest and apoptosis in cancer cells, along with neuro-protective effects, further underscores its potential as a therapeutic agent for a range of conditions. Despite its potential, the low bioavailability and solubility of Decursinol Angelate have posed challenges for its development as a drug, prompting researchers to explore innovative strategies to enhance its delivery and effectiveness.

130848-06-5

Post Buying Request

130848-06-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • ≥97% high purity high quality custom manufacturing natural extract Decursinol?angelate;Acutilobin;Decursinol mebutate 130848-06-5

    Cas No: 130848-06-5

  • No Data

  • No Data

  • No Data

  • Sinoway Industrial Co., Ltd.
  • Contact Supplier

130848-06-5 Usage

Uses

Used in Pharmaceutical Industry:
Decursinol Angelate is used as a therapeutic agent for its anti-inflammatory properties, helping to reduce inflammation and alleviate symptoms associated with various inflammatory conditions.
Used in Oncology:
Decursinol Angelate is used as an anti-cancer agent, leveraging its ability to induce cell cycle arrest and apoptosis in cancer cells, thereby inhibiting tumor growth and progression.
Used in Neuroprotection:
Decursinol Angelate is used as a neuroprotective agent, offering potential benefits in the treatment and management of neurodegenerative diseases and conditions involving neuronal damage.
Used in Drug Delivery Systems:
To address the limitations of Decursinol Angelate's low bioavailability and solubility, researchers are developing novel drug delivery systems. These systems aim to enhance the compound's delivery, bioavailability, and therapeutic outcomes, potentially improving its effectiveness as a pharmaceutical agent.

Check Digit Verification of cas no

The CAS Registry Mumber 130848-06-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,8,4 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 130848-06:
(8*1)+(7*3)+(6*0)+(5*8)+(4*4)+(3*8)+(2*0)+(1*6)=115
115 % 10 = 5
So 130848-06-5 is a valid CAS Registry Number.

130848-06-5Downstream Products

130848-06-5Relevant articles and documents

Decursinol angelate ameliorates 12-O-tetradecanoyl phorbol-13-acetate (TPA) -induced NF-κB activation on mice ears by inhibiting exaggerated inflammatory cell infiltration, oxidative stress and pro-inflammatory cytokine production

Chang, Sukkum Ngullie,Khan,Dey, Debasish Kumar,Cho, Kiu-Hyung,Hwang, Buyng Su,Bae, Ki Beom,Kang, Sun Chul,Park, Jae Gyu

, (2019)

Decursinol angelate (DA) is a pyranocoumarin purified from the roots of Angelica gigas. Here, we synthesized DA and determined its anti-inflammatory potential on TPA-induced mice ear inflammation. First, we evaluated the non-toxic behaviour of DA on HaCaT cells. Additionally, we observed the free radical scavenging potential of DA at 60 μM to be 50%. This finding was further supported by nitric oxide assay, malondialdehyde assay, H2DCFDA staining and western blotting analysis of antioxidant enzymes. DA also suppressed the activation and polarization of macrophage phagocytic activity on RAW 264.7 cells. We further evaluated the expression of ICAM-1, MCP-1, MIP-2 and MIP-1β on in-vivo model system. Consequently, DA significantly reduced the production of NF-κB and COX-2 induced proinflammatory cytokine levels on TPA induced ear edema. Inhibition of MAPK and transcriptional factor NF-κB was also validated by western blotting analysis of p-ERK, p-p38, IKKα, IKKγ, IκBα, NF-κB-p65. Immunohistochemistry and immunofluorescence staining of NFκB-p65, TNF-α and IL-1β were also performed to support the findings. Conclusively, these results suggest that topical administration of DA significantly inhibited the expression of pro-inflammatory cytokines by blocking the canonical NF-κB and MAPK pathway. Therefore, we suggest DA as a potent therapeutic compound against skin inflammation related diseases.

Enantioselective syntheses of decursinol angelate and decursin

Lim, Jongdoo,Kim, Ik-Hwan,Kim, Hyeon Ho,Ahn, Kyung-Seop,Han, Hogyu

, p. 4001 - 4003 (2001)

The practical enantioselective syntheses of decursinol angelate and decursin were achieved in eight steps from resorcinol. The stereochemistry was addressed using the catalytic asymmetric epoxidation of 7-acetoxy-2,2-dimethylchromene by chiral (salen)Mn complexes as the key step.

Synthesis of (S)-(+)-decursin and its analogues as potent inhibitors of melanin formation in B16 murine melanoma cells

Lee, Kyeong,Lee, Jee-Hyun,Boovanahalli, Shanthaveerappa K.,Choi, Yongseok,Choo, Soo-Jin,Yoo, Ick-Dong,Kim, Dong Hee,Yun, Mi Young,Lee, Gye Won,Song, Gyu-Yong

experimental part, p. 5567 - 5575 (2011/02/22)

We report the synthesis of a novel series of highly potent melanin inhibitors which were obtained through structural modification of an anticancer compound S-(+)-decursinol. The in vitro inhibitory potencies of the newly synthesized compounds were evaluated against α-MSH induced melanin production in B16 murine melanoma cells. Among the compounds evaluated, compounds 2, 3, 6b, 7a, 7b, 8a and 8b emerged as highly potent inhibitors of melanin production. Besides, these compounds demonstrated significantly low cytotoxicity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 130848-06-5